Position in DHR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$399,627
+$330 QoQ
Shares Held
2,098
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,485
of 2,098 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARGUS INVESTORS' COUNSEL, INC. holds $864,889 across 2 Diagnostics & Research names. DHR ranks #2 (46.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
928 | $465,262 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
2,098 | $399,627 |
All Filings in DHR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $399,627 | 2,098 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $399,297 | 2,106 | Shares | Sole | 2026-04-28 | |
| 2023-12-31 | $676,669 | 2,925 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $696,168 | 2,806 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $779,280 | 3,247 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,689,676 | 6,704 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,748,055 | 6,586 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,684,309 | 6,521 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $1,559,148 | 6,150 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,642,941 | 5,601 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $828,776 | 2,519 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $574,782 | 1,888 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $394,757 | 1,471 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $203,922 | 906 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||